Haematology 2018

36% patients discontinued

PFS

OS

therapy as a result of toxicity (vs 16% placebo)

72% required a dose reduction

55% aged <70..? Fit for an alternative approach PET positive at end of induction had greatest benefit (HR=0.59 vs 0.78)

Thieblemont et al. JCO 2017